Bionaut Labs is focused on revolutionizing the treatment of central nervous system disorders with its Bionaut™ precision medicine treatment modality that uses remote-controlled microscale robots to deliver biologics, nucleic acids, or small molecule therapies locally to targeted disease areas. With the Bionaut™ medical modality, Bionaut Labs can transform the way the biopharmaceutical industry develops treatments, allowing the Company to engineer the therapeutic index for better efficacy and safety. Led by a world-class team of medical, engineering, and drug development experts, Bionaut Labs' headquarters is in Los Angeles, California, with additional R&D sites in Israel and at the Max Planck Institute in Germany.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
03/04/21	$20,000,000	Seed	Bold Capital Compound Khosla Ventures Revolution LLC Upfront Ventures	undisclosed
11/28/22	$43,200,000	Series B	Bold Capital Compound Deep Insight Dolby Family Ventures Gaingels GISEV Family Office Khosla Ventures OurCrowd PSPRS Revolution Ventures Sixty Degree Capital Tintah Grace Upfront Ventures What If Ventures	undisclosed